StonvexLoading…
StonvexStonvexStonvexCore line items from UGRO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 | Annual 2023 2023-06-30 |
|---|---|---|---|---|
Revenue | $40.01M | $69.92M | $54.79M | $35.21M |
Operating Income | $-28.42M | $-23.29M | $-12.74M | $-9.23M |
Net Income | $-36.50M | $-25.44M | $-14.84M | $-11.02M |
EPS (Diluted) | $-2.62 | $-2.34 | $-1.37 | $-1.01 |
Total Assets | $19.49M | $49.51M | $54.97M | $59.02M |
Total Liabilities | $44.14M | $39.43M | $35.10M | $36.13M |
Cash & Equivalents | $819.05K | $1.07M | $4.50M | $8.29M |
Free Cash Flow OCF − CapEx | $-2.95M | $-11.06M | $-6.60M | $-1.52M |
Shares Outstanding | 504.86K | 12.07M | 10.86M | 10.86M |